Mentions
Extended reach
Total likes
Video views
AI synopsis
Several discussions mention the study's focus on the demographic characteristics of affected children, such as stating that 'children with MIS-C are more likely to be aged 6-12 and predominantly non-Hispanic Black.' The tone shows urgency concerning the implications of these findings on public health, especially indicated by phrases like 'critical understanding of this syndrome' and 'higher ICU rates with MIS-C cases,' reflecting a serious concern for the health of young patients.
Many commenters express support for the study's findings, acknowledging its relevance in understanding MIS-C compared to severe COVID-19.
There is high curiosity in the discussions, with participants sharing key data points and personal perspectives regarding children's health outcomes.
Most posts indicate moderate engagement, although some delve into technical aspects, highlighting their interest in specific statistics and case comparisons.
The sentiment suggests that users believe the study has significant implications for understanding long-term health consequences of COVID-19 in children.
Dr. Adrienne Randolph speaking about the important work by @OvercomingCOVID Investigators @PALISInet @CDCgov with @burns_md @OPENPediatrics @ ➡️ https://t.co/3hEUFrLLuQ via @YouTube Preparedness and foresight in an emergency #COVIDー19 https://t.co/cL8ZnvmhNp
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19 https://t.co/We6S1tm4pO #PediNeuroRad @JAMA_current https://t.co/DZtm4HToHT
@fabrn01 @_b_meyer @CHOP_ID Almost 2% of children with MIS-C have died. Most have required hospitalization and often ICU support, but so far cardiac recovery fortunately looks pretty good. Long-term outcomes of course yet unknown: https://t.co/r2r1UlVPvk
In this case series using national #MISC registry data, kids w MIS-C were younger (6-12 y), more likely to be non-Hispanic Black, & have severe CV or mucocutaneous involvement and more extreme inflammation vs kids w severe #COVID19 https://t.co/LgMSSs57j7 @BostonChildrens
Chez les enfants/ados : 1 syndrome inflammatoire multisystémique post-coronavirus tous les 3 200 infections au SARS-CoV-2 Chez ces cas, 60-70% sont admis en soins intensifs et 1-2% en décèdent https://t.co/9VZ7Pqbru5 https://t.co/OxTz9odLZB https://t.co/u9WkMlTHN8
多系統炎症性症候群患者の特徴は 6-12歳 非ヒスパニック系黒人 重度の心血管系/粘膜皮膚病変 高度な炎症等 Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19 https://t.co/8j3sk2DnWA https://t.co/4aAIhaNg8M https://t.co/ZCatkFnEUO
Dr. Adrienne Randolph discusses the epidemiology, clinical characteristics, and outcomes of pediatric patients diagnosed with MIS-C compared to severe COVID-19. Key insights include distinguishing features and the…
RT @falsel_net: International reports of #COVID19–related severe complications in #children began April 2020 when predominantly healthy chi…
#けんさんジャーナル #読了 https://t.co/BfP9gZALY1 MIS-C患者は好中球/リンパ球比が高く（中央値、6.4 vs 2.7、P < 0.001）、CRP値が高く（中央値、152mg/L vs 33mg/L、P < 0.001）、血小板数が少なかった（<150×103 cells/μL [212/523 {41%} vs 84/486 {17%}、P < 0.001]）。
@telakoya @mugen_atomic @studiocorvo @sinebalta https://t.co/qjHd5B6GqM
@JustinTrudeau https://t.co/X2bIT85HXX While you disease, disable and cause death to Canadian youth with an airborne Biohazard
https://t.co/X2bIT85a8p
RT @carpe_diem0820: 多系統炎症性症候群患者の特徴は 6-12歳 非ヒスパニック系黒人 重度の心血管系/粘膜皮膚病変 高度な炎症等 Characteristics and Outcomes of US Children and Adolescents Wit…
@DGKJ_eV @dgpi "Patienten mit Risikofaktoren können potentiell einen schweren Verlauf haben" Richtig ist imho: ~ 1/3 der "severe" und ~ 2/3 der MIS-C Fälle sind ohne jede Komorbidität. Siehe auch hier: https://t.co/2iz4MiOjQ5 und hier: https://t.co/IGnutAw7t8
@DrBrandonMSmith @KrugAlli @VPrasadMDMPH Thanks for this! I overlooked the CDC included adults in the cases count. Seems... not good. I'm seeing 44-100% MIS-C requiring ICU. Not clear how much Delta this captures but the MIS-C ICU rate is 73.8%. C19 ICU seems high at 43%. https://t.co/P6GKggIWvL
@walidgellad @AngryCardio @KrugAlli Did this one have anything useful? Pre-vax. https://t.co/pyOSvrq9VU
@IMhospitalist80 @RogueRad @walidgellad Anything here? https://t.co/pyOSvrpC6m
@WaldinoE https://t.co/HD3KohjHWo
RT @Jason_N_Johnson: ✅Cor artery dilat → up to 50% of MISC ✅Giant (Z-score >10 or diam > 8 mm) cor aneurysm RARE in MISC https://t.co/dFSF…
✅Cor artery dilat → up to 50% of MISC ✅Giant (Z-score >10 or diam > 8 mm) cor aneurysm RARE in MISC https://t.co/dFSFBSGYOm Mid-term #WhyCMR after MISC usually normal but more data needed https://t.co/mgZYJWj8mE 6/ #WhyCMR #CTA @SCMROrg https://t.co/P16sQVO4Az
@PhysicsRocks3 @tzvitessler במאמר הספציפי עליו פיזיקס כתבה (דאטא צרפתי) 88% נזקקו לאשפוז בטפנ"צ. מצרף פה מאמר נוסף מארה"ב ובו 74% נזקקו לאשפוז בטפנ"צ. https://t.co/Cc8CxGt2eq
RT @SixandLaura: Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Com…
@Preferthefacts @mattjayyyymes @kid_prairie @ReutersFacts "multicenter case series of 1116 patients <21 years of age hospitalized w MIS-C or acute severe COVID-19, children w MIS-C more likely to be age 6-12yrs of age & have severe cardiovascular or mucocutaneous involvement & more extreme levels of inflammation" https://t.co/64Nkn7lBa1
RT @DrPedsRheum: Next is cardiac dysfunction, echo, and imaging biomarkers w/ Dr Tejtel #MISC #PedsRheum #ACR21
Next is cardiac dysfunction, echo, and imaging biomarkers w/ Dr Tejtel #MISC #PedsRheum #ACR21
Going back to the definition of MIS-C which is broad Use of the Overcoming COVID-19 network to distinguish MIS-C from severe COVID-19 https://t.co/RNFHneOcoG #ACR21 https://t.co/7FylBMOvrb
Cardiovascular involvement common & prominent Feldstein, et al: https://t.co/RNFHneOcoG #ACR21 https://t.co/yeMfsex4dU
RT @SixandLaura: Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Com…
@AminSharaf @Minyas49866842 @Fred_S_at Das ist einfach Unsinn. https://t.co/Eu8s7NhRaI 2 seit Jahrzehnten pensionierte Ärzte (wie Bhakdi) und ein pensionierter Elektrotechniker, die Unsinn verzapfen. https://t.co/5SlDjId2QQ https://t.co/HSf4Vrtxaq
RT @SixandLaura: Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Com…
@gadboit @julietast2 @void2546667 @Stockdog23 Link: https://t.co/b9uURVe5QI Btw I don’t understand how if obesity is an underlying condition there are 176 MIS-C cases with obesity but only 167 MIS-C cases with at least 1 underlying condition but anyway
@ExoExplorer3 @Catlove40476297 https://t.co/dx6GA44byY
RT @carpe_diem0820: 多系統炎症性症候群患者の特徴は 6-12歳 非ヒスパニック系黒人 重度の心血管系/粘膜皮膚病変 高度な炎症等 Characteristics and Outcomes of US Children and Adolescents Wit…
Feldstein, Leora R.,et al. "Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19." JAMA 325.11 (2021): 1074-1087. https://t.co/3vT78jumNT
@maaritalexandra @TerhiTapiainen @andreasblanco @LK43317364 @myllarni @NieminenTea Yhdysvalloissa MIS-C on esiintynyt n. 300 lapsella 1 milj. koronavirusinfektiotapausta kohden eli n. 0,3 % ilmaantuvuudella. Sydänoireet vaarallisimpia. Ennuste kuitenkin hyvä eli useimmat toipuvat n. 2 viikossa https://t.co/YByhE1V0dj
Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19 Case series of 1116 patients aged younger than 21 years hospitalized between March 15 and October 31, 2020, at 66 US hospitals in 31 states https://t.co/odtvZjE3Tm
RT @SixandLaura: Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Com…
RT @SixandLaura: Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Com…
Overcoming COVID consortium results: https://t.co/vZIOUK6wzf and International Best Treatment Available: https://t.co/VOmf4iMquN #stopviruscollab https://t.co/XhL7DvpBEd
@welt Datenlage ist Ausreichend?
@CDewotine @sahab95219938 @hellidu @DavidPerso2 @GeffierD @LaureGonlezamar @AnaisLefaucheux @AdeSouzy tiens c'est bizarre si les enfants n'ont aucun risque de développer des formes graves peut on dire que les enfants décédés du covid sont des simulateurs très très forts.? https://t.co/ss9qSDJX2c
@dperetti @jerry_isabelle @Mediavenir ben vous lirez alors cet article de synthèse sur les hospitalisations, réanimation et décès d'enfants atteints de la covid et vous corrigerez l'énormité que vous avez écrite. https://t.co/ss9qSDJX2c
@Pianowoman18 MIS-C cases occur in 1 per 3000 or so patients: https://t.co/35AD87EaLV Myocarditis is found in ~75% of them in association with a host of other problems: https://t.co/71DQAR22ty That makes the risk ~1 per 4000. With vaccines it goes up to 70/million second doses.
@andrewbostom @drsarah041 @Maples46014332 @TracyBethHoeg https://t.co/F77AF4mf6a. See figure 2. MIS-C highly concentrated ages 12 and under.
Hipokryci!!!! @szczepimysie To sa badania na ktore wy sie powolujecie.
@contrarian4data @PN_1984 @pickleoodles @ebennett74 @districtai @covid_clarity @EWoodhouse7 Whatever the alleged C19 assoc "MIS" rate is cut it in half! “In patients with MIS-C, 52% had a positive SARS-CoV-2 RT-PCR test result, 45% were SARSCoV- 2 antibody positive only” https://t.co/0QEAbSKora
RT @T_Fiolet: Chez les enfants/ados : 1 syndrome inflammatoire multisystémique post-coronavirus tous les 3 200 infections au SARS-CoV-2 Ch…
RT @T_Fiolet: Chez les enfants/ados : 1 syndrome inflammatoire multisystémique post-coronavirus tous les 3 200 infections au SARS-CoV-2 Ch…
RT @T_Fiolet: Chez les enfants/ados : 1 syndrome inflammatoire multisystémique post-coronavirus tous les 3 200 infections au SARS-CoV-2 Ch…
RT @T_Fiolet: Chez les enfants/ados : 1 syndrome inflammatoire multisystémique post-coronavirus tous les 3 200 infections au SARS-CoV-2 Ch…
RT @T_Fiolet: Chez les enfants/ados : 1 syndrome inflammatoire multisystémique post-coronavirus tous les 3 200 infections au SARS-CoV-2 Ch…
Chez les enfants/ados : 1 syndrome inflammatoire multisystémique post-coronavirus tous les 3 200 infections au SARS-CoV-2 Chez ces cas, 60-70% sont admis en soins intensifs et 1-2% en décèdent https://t.co/9VZ7Pqbru5 https://t.co/OxTz9odLZB https://t.co/u9WkMlTHN8
RT @odomjohnlab: @fabrn01 @_b_meyer @CHOP_ID Almost 2% of children with MIS-C have died. Most have required hospitalization and often ICU s…
RT @odomjohnlab: @fabrn01 @_b_meyer @CHOP_ID Almost 2% of children with MIS-C have died. Most have required hospitalization and often ICU s…
RT @odomjohnlab: @fabrn01 @_b_meyer @CHOP_ID Almost 2% of children with MIS-C have died. Most have required hospitalization and often ICU s…
RT @odomjohnlab: @fabrn01 @_b_meyer @CHOP_ID Almost 2% of children with MIS-C have died. Most have required hospitalization and often ICU s…
RT @odomjohnlab: @fabrn01 @_b_meyer @CHOP_ID Almost 2% of children with MIS-C have died. Most have required hospitalization and often ICU s…
@fabrn01 @_b_meyer @CHOP_ID Almost 2% of children with MIS-C have died. Most have required hospitalization and often ICU support, but so far cardiac recovery fortunately looks pretty good. Long-term outcomes of course yet unknown: https://t.co/r2r1UlVPvk
RT @KerriLarovere: Dr. Adrienne Randolph speaking about the important work by @OvercomingCOVID Investigators @PALISInet @CDCgov with @burns…
@conservtvcnd @karenzylak @AlexBerenson 24% of cases this week have been kids/teens. 3.85 million cases have been kids. 200,000 hospitalizations and 300+ deaths. Those hospitalized have experienced neuro, cardio, and systemic complications (MIS-C). & then 43,000+ kids have lost a parent(s). https://t.co/OMdcV0nZqW
https://t.co/Pea51nNEqb
RT @GacetaCienForen: Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C)…
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19 - https://t.co/77A4zSMVT2
RT @ESPNIC_Society: How do the characteristics and outcomes of children and adolescents with multisystem inflammatory syndrome in #children…
@LaVillegas1 @SDyAmor “hipótesis de que el MIS-C era en su mayoría posinfeccioso y distinto del COVID-19 porque las muestras respiratorias de muchos pacientes eran negativas para el SARS-CoV-2 y el MIS-C alcanzó su punto máximo después de los casos de COVID-19 notificados” https://t.co/CYCfjhoq0y
RT @ESPNIC_Society: How do the characteristics and outcomes of children and adolescents with multisystem inflammatory syndrome in #children…
RT @ESPNIC_Society: How do the characteristics and outcomes of children and adolescents with multisystem inflammatory syndrome in #children…
RT @ESPNIC_Society: How do the characteristics and outcomes of children and adolescents with multisystem inflammatory syndrome in #children…
How do the characteristics and outcomes of children and adolescents with multisystem inflammatory syndrome in #children (MIS-C) compare with severe coronavirus disease 2019 #COVID19 ? Everything you'll like to know about it, here
@TrishtheSkeptic @ZachFoughty @AfflerDavid over 500 in NY alone https://t.co/MoHAghsDuJ
RT @JAMAPediatrics: In this case series using national #MISC registry data, kids w MIS-C were younger (6-12 y), more likely to be non-Hispa…
RT @JAMAPediatrics: In this case series using national #MISC registry data, kids w MIS-C were younger (6-12 y), more likely to be non-Hispa…
In this case series using national #MISC registry data, kids w MIS-C were younger (6-12 y), more likely to be non-Hispanic Black, & have severe CV or mucocutaneous involvement and more extreme inflammation vs kids w severe #COVID19 https://t.co/HmOlVVVQkB @BostonChildrens
In this case series using national #MISC registry data, kids w MIS-C were younger (6-12 y), more likely to be non-Hispanic Black, & have severe CV or mucocutaneous involvement and more extreme inflammation vs kids w severe #COVID19 https://t.co/dtVr0UixsP @BostonChildrens
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19 | Critical Care Medicine | JAMA | JAMA Network https://t.co/rKRjHm695L
https://t.co/e1qADlPnFc
https://t.co/HHKU95KVyJ
In this case series using national #MISC registry data, kids w MIS-C were younger (6-12 y), more likely to be non-Hispanic Black, & have severe CV or mucocutaneous involvement and more extreme inflammation vs kids w severe #COVID19 https://t.co/vkXVOVsVno @BostonChildrens
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19 | Critical Care Medicine | JAMA | JAMA Network https://t.co/wrXL3E6qx1
Characteristics and Outcomes of US Children and Adolescents With MIS-C Compared With Severe Acute COVID-19 https://t.co/AKEDb7kyfx via @JAMA_current part of @JAMANetwork
RT @KerriLarovere: Dr. Adrienne Randolph speaking about the important work by @OvercomingCOVID Investigators @PALISInet @CDCgov with @burns…
RT @KerriLarovere: Dr. Adrienne Randolph speaking about the important work by @OvercomingCOVID Investigators @PALISInet @CDCgov with @burns…
RT @KerriLarovere: Dr. Adrienne Randolph speaking about the important work by @OvercomingCOVID Investigators @PALISInet @CDCgov with @burns…
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19 https://t.co/jr2jCJ9D0J
RT @ASHPOfficial: Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Co…
RT @KerriLarovere: Dr. Adrienne Randolph speaking about the important work by @OvercomingCOVID Investigators @PALISInet @CDCgov with @burns…
RT @ASHPOfficial: Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Co…
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. https://t.co/99PPR6AEzU @JAMA_current
RT @KerriLarovere: Dr. Adrienne Randolph speaking about the important work by @OvercomingCOVID Investigators @PALISInet @CDCgov with @burns…
Dr. Adrienne Randolph speaking about the important work by @OvercomingCOVID Investigators @PALISInet @CDCgov with @burns_md @OPENPediatrics @ ➡️ https://t.co/3hEUFrLLuQ via @YouTube Preparedness and foresight in an emergency #COVIDー19 https://t.co/cL8ZnvmhNp
Characteristics and Outcomes of US Children and Adolescents With MIS-C Compared With Severe Acute COVID-19 https://t.co/SfCJoTpxBW via @JAMA_current part of @JAMANetwork @MOSchNurses
Characteristics and Outcomes of US Children and Adolescents With MIS-C Compared With Severe Acute COVID-19 https://t.co/jqIG61Eg0i via @JAMA_current part of @JAMANetwork @schoolnurses @TxSchlNurses
Characteristics and Outcomes of US Children and Adolescents With MIS-C Compared With Severe Acute COVID-19 https://t.co/nl9ipQHQUz via @JAMA_current part of @JAMANetwork
Characteristics and Outcomes of US Children and Adolescents With MIS-C Compared With Severe Acute COVID-19 https://t.co/niLYY9zGdf via @JAMA_current part of @JAMANetwork
national MIS-C registry data, patients with MIS-C were more likely than those with severe #COVID19 to be 6-12 years old, be non-Hispanic Black, and have severe cardiovascular or mucocutaneous involvement and more extreme inflammation. https://t.co/U0L3ruJh1G
Características y resultados de niños y adolescentes estadounidenses con síndrome inflamatorio multisistémico en niños (MIS-C) en comparación con COVID-19 agudo severo https://t.co/wNR91qUvuL
RT @JAMA_current: In this case series using national #MISC registry data, kids w MIS-C were younger (6-12 y), more likely to be non-Hispani…
RT @JAMA_current: In this case series using national #MISC registry data, kids w MIS-C were younger (6-12 y), more likely to be non-Hispani…
RT @JAMA_current: In this case series using national #MISC registry data, kids w MIS-C were younger (6-12 y), more likely to be non-Hispani…
RT @JAMA_current: In this case series using national #MISC registry data, kids w MIS-C were younger (6-12 y), more likely to be non-Hispani…
RT @JAMA_current: In this case series using national #MISC registry data, kids w MIS-C were younger (6-12 y), more likely to be non-Hispani…
In this case series using national #MISC registry data, kids w MIS-C were younger (6-12 y), more likely to be non-Hispanic Black, & have severe CV or mucocutaneous involvement and more extreme inflammation vs kids w severe #COVID19 https://t.co/LgMSSs57j7 @BostonChildrens
@HikariGoi @WDRaktuell https://t.co/wIrim0YzUR https://t.co/3lIi3YZnDY https://t.co/3l9E7fzr3h Das sind nur einige Berichte zu den Folgen von Covid-19-Infektionen.
Which clinical features might differentiate MIS-C from severe COVID-19 in children? https://t.co/ra6kwESq6N Shared from Epocrates, The #1 medical reference app. https://t.co/6B3jbzYYWk https://t.co/ZUkPHHWdnc
@Miellettes @chaosimkittel Na ja. "Überwiegende Mehrheit" ist auch auf erwachsene zutreffend. Das ist sehr dehnbar. Ich habe hier 2 liegen: https://t.co/tNye1Q9oMg und https://t.co/BW5akl67Tc 576 im KH (="ernst") und noch einmal so viele mit MIS-C (PIMS) Insg. 1/10 der Erwachsenen-Quote von 16/10.000 https://t.co/18dsNq8kRo
https://t.co/uql7CslvkF
Characteristics and Outcomes of US Children and Adolescents With #MISC Compared With Severe Acute #COVID19 https://t.co/yKMpfwF2w2 via @JAMA_current part of @JAMANetwork
RT @atscommunity: Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) co…
RT @atscommunity: Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) co…
Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute #COVID19: https://t.co/P1pw1NwiQl
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19 | Critical Care Medicine | JAMA | JAMA Network https://t.co/GcoysMNeRU
RT @atscommunity: Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) co…
RT @atscommunity: Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) co…
Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute #COVID19: https://t.co/P1pw1NwiQl
Trending on PubMed: Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. https://t.co/lO2qoft4dM
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19 2/24/2021 Case series 1116 patients <21 hospitalized 3/15-10/31 #SARSCoV2 #timeline #MIS #COVID19 https://t.co/OOuNNiVLv2
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19 https://t.co/vZbombpBi7
RT @The_ASPNR: Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compa…
RT @The_ASPNR: Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compa…
RT @The_ASPNR: Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compa…
RT @The_ASPNR: Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compa…
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19 https://t.co/We6S1tm4pO #PediNeuroRad @JAMA_current https://t.co/DZtm4HToHT
RT @carpe_diem0820: 多系統炎症性症候群患者の特徴は 6-12歳 非ヒスパニック系黒人 重度の心血管系/粘膜皮膚病変 高度な炎症等 Characteristics and Outcomes of US Children and Adolescents Wit…
Trend up+3: Feldstein LR, ..., Overcoming COVID-19 Investigators (JAMA) __Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19__ https://t.co/KEF2bZGVf1
多系統炎症性症候群患者の特徴は 6-12歳 非ヒスパニック系黒人 重度の心血管系/粘膜皮膚病変 高度な炎症等 Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19 https://t.co/8j3sk2DnWA https://t.co/4aAIhaNg8M https://t.co/ZCatkFnEUO
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19 | Critical Care Medicine | JAMA | JAMA Network https://t.co/xXsj1H3HcZ
@MiguelrrMD Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. JAMA. doi:10.1001/jama.2021.2091 Published online February 24, 2021.
RT @RobustosMD: #PedsICU #Covid19 #PIMS#MIS-C ☝️1116 pt in 66 US Hospitals Characteristics and Outcomes of US Children and Adolescents With…
RT @RobustosMD: #PedsICU #Covid19 #PIMS#MIS-C ☝️1116 pt in 66 US Hospitals Characteristics and Outcomes of US Children and Adolescents With…
RT @RobustosMD: #PedsICU #Covid19 #PIMS#MIS-C ☝️1116 pt in 66 US Hospitals Characteristics and Outcomes of US Children and Adolescents With…
#PedsICU #Covid19 #PIMS#MIS-C ☝️1116 pt in 66 US Hospitals Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19 | Pediatrics | JAMA | JAMA Network https://t.co/sbPkFLDVaR
New article: Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19 https://t.co/O4oBossoAb #coronavirus #COVID19 #2019ncov https://t.co/6osZ5Ksxg9